Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "8"

Research

Data Resource Profile: The South Australian Well-being and Engagement Collection (WEC)

Mental health and well-being during childhood and adolescence have been shown to impact on health, educational attainment and employment in adulthood.1–3 Although health and education systems worldwide have long recognized the importance of promoting student well-being,4–6 population-wide monitoring of well-being remains uncommon.

Research

Common Pathways to NSSI and Suicide Ideation: The Roles of Rumination and Self-Compassion

The salience of self-compassion offers promise for early intervention initiatives focusing on less judgmental or self-critical means of self-relation

Research

Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: Findings from the pregnancy and childhood epigenetics (PACE) consortium

we meta-analysed the association between pre-pregnancy maternal BMI and methylation at over 450,000 sites in newborn blood DNA, across 19 cohorts.

Research

Climate clever clovers: New paradigm to reduce the environmental footprint of ruminants by breeding low methanogenic forages utilizing haplotype variation

We demonstrate the feasibility of a plant breeding approach without compromising animal productivity to mitigate enteric methane emissions, which is one of the most significant challenges to global livestock production.

Positive Family Foundations

Enhancing psychological wellbeing in families from pregnancy to infancy

Fundraise

You are so valuable to us! Not only can you help fund our research into what makes kids healthy and happy, but you can also raise awareness of how important that work is.

Data Manager Wesfarmers Centre of Vaccines and Infectious Diseases

Newly created role to provide data management support across a range of projects

Research

Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis

Nirsevimab is a long-acting monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in infants and high-risk children. During the 2024 RSV season in Western Australia, 21 922 doses were administered to infants entering their first season and 1221 doses to at-risk children. In this context, the selection and spread of escape variants are a potential concern. This study aimed to investigate nirsevimab binding site mutations using clinical and wastewater data.

Guidelines, reports and books

We have recently developed recommendations to support clinical practice for gastro-intestinal disorders including growth and scoliosis in Rett syndrome.